ONCS Financials 07/16/2014 15:24:37 OncoSec Medic
Post# of 121
OncoSec Medical Incorporated
Period Ending Jul 31, 2013 Jul 31, 2012 Jul 31, 2011 Jul 31, 2010
Total Revenue - - - -
Cost of Revenue - - - -
Gross Profit - - - -
Operating Expenses
Research and Development 3,159 2,368 648 -
Sales, General and Admin. 3,906 3,159 1,047 27
Non-Recurring Items - - - 9
Other - - - -
Operating Income (7,065) (5,527) (1,695) (27)
Income From Continuing Operations
Add'l Income/Expense Items - 3,431 (2,060) -
Earnings Before Interest and Tax (7,065) (2,096) (3,756) (36)
Interest Expense 83 267 1 -
Earnings Before Tax (7,148) (2,362) (3,757) (36)
Income Tax 2 2 2 -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (7,150) (3,126) (3,759) (36)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (7,150) (2,365) (3,759) (36)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (7,150) (2,365) (3,759) (36)